Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more
Waters acquires DESI-MS technology from Prosolia
Desorption Electrospray Ionization (DESI) imaging gives deeper biological insights
Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF.
"The acquisition of DESI technology bolsters Waters' portfolio of mass spectrometry imaging innovations, a rapidly expanding MS technique for biomedical research and related applications," said Chris O'Connell, Chairman and Chief Executive Officer, Waters Corporation. "DESI mass spectrometry imaging provides complementary and actionable data when compared to classical histopathology imaging technologies with major advantages in analyzing the molecular fingerprint within a sample, thus delivering deeper biological insights. Ultimately, these insights will lead to better understanding of disease and enable the development of new, more effective medical therapies."
DESI imaging technology uses a charged jet of solvent depositing micro-droplets onto a sample's surface where analytes are desorbed into a gas phase at ambient pressure and temperature. Subsequently, they are drawn in and analyzed by mass spectrometry.
"We at Prosolia are proud of our role in developing and commercializing DESI technology," said Justin Wiseman, Chief Executive Officer, Prosolia. "The potential for MSI analysis using DESI technology is significant because of the quality of the data, the minimal sample preparation required, and the non-destructive nature of the technique allowing for multimodal analysis on a single sample."
In connection with Waters’ acquisition of DESI intellectual property from Prosolia and licensing from PRF, Waters and Purdue University, where DESI was invented by a team led by R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry, have also established a relationship under the terms of a new license agreement. Accordingly, Waters will provide Purdue University with a Synapt™ G2-Si time-of-flight mass spectrometer to continue to advance research applications of DESI technology.
"Today's announcement is an important milestone in the continued growth of DESI to the benefit of scientists around the globe. We congratulate Justin and the Prosolia team for their accomplishments and look forward to collaborating with Waters as it takes DESI into the future," commented Dr. Cooks.
- mass spectrometry
- desorption electros…
- technology transfer
Waters Corporation announced that it entered into a co-marketing agreement with Malvern Panalytical to advance the analysis of polymers. By pairing the Waters ® ACQUITY ® Advanced Polymer Chromatography ® (APC ™ ) System with Malvern Panalytical’s OMNISEC ® REVEAL , R&D scientists can acces ... more
Waters Corporation announced that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017. The Board of Directors has elected Christopher J. O'Connell, President and Chief Executive Officer, as its new Chairman effective January 1, ... more
Combines novel cyclic ion mobility separation with superior time-of-flight mass spectrometry ✓ Trennen Sie mit ultimativer Auflösung in der Ionenmobilität mehr als jemals zuvor für absolute Sicherheit more
Maximum performance: more analytes per injection and larger concentration ranges - on a small footprint, at an affordable price more
Our products are manufactured to industry benchmark quality requirements by our world-class manufacturing organization and supported by our highly skilled sales and support teams more
Leading researchers are discovering the promise of the SELECT SERIES™ Cyclic™ IMS. This revolutionary new instrument combines novel cyclic ion mobility (cIMS) separation with state-of-the-art, high-performance, time-of-flight mass spectrometry, to help bring you to the forefront of scientif ... more
The BioAccord system enables even users without expert knowledge to generate and evaluate LC-MS data on the spot in the biopharmaceutical lab, tasks that until now had to be performed in centralized MS laboratories. From development to QC, the system makes the analysis of biotherapeutic pro ... more
Analytical laboratories working at full capacity are faced with the challenge of ensuring a comprehensive coverage of applications while working time and cost efficiently. This balancing act is now possible thanks to the Xevo TQ-GC mass spectrometer. Your results are reproducible even with ... more
Gene editing has been a much sought after and controversial technology. Last month, part of the World Health Organization called for an international registry to track all research into editing the human genome. Purdue University researchers, including one who was inspired by the cancer dea ... more
Purdue University researchers have developed a technology aimed at making it easier to deliver cancer treatment to the right "address" in the body while also easing the painful side effects of chemotherapy on patients. One of the big issues with chemotherapy is that most treatment approache ... more
Purdue University researchers have developed a new flexible and translucent base for silicon nanoneedle patches to deliver exact doses of biomolecules directly into cells and expand observational opportunities."This means that eight or nine silicon nanoneedles can be injected into a single ... more
A new automated system detects cracks in the steel components of nuclear power plants and has been shown to be more accurate than other automated systems. more
- 1New Indication of a Link Between Alzheimer’s and Diabetes
- 2Click... Resistant bacteria caught in the act!
- 3The relationship of proteins
- 4Nanosafety research without animal experiments
- 5Could the blood of COVID-19 patients be used to predict disease progression?
- 6Taking a deep look into animals
- 7Detecting antibodies with glowing proteins, thread and a smartphone
- 8RNA structures by the thousands
- 9DKSH extends partnership with Bruker in China
- 10Snapshot of exploding oxygen
- Beckman Coulter strenghtens laboratory automation business
- Waters acquires DESI-MS technology from Prosolia
- Agilent aigns agreement to acquire assets from Young In Scientific Co. Ltd.
- Zeiss strenghtens in-house quality and production management
- Oxford Nanopore raises 140M € from international investors